Institutional Ownership
Oramed Pharmaceuticals Inc
CUSIP 68403P203COM NEWORMPQ1 2026
13D / 13G Filings
10
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
8.3%
Max % of class reported
Institutional Holders
64
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
10 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | Bml Investment Partners, L.P. | 13G/A | 8.3% | 3.29M | SEC |
| 2 | Aug 28, 2025 | Nadav Kidron | 13D/A | 7.6% | — | SEC |
| 3 | Feb 13, 2025 | Bml Investment Partners, L.P. | 13G/A | 6.5% | 2.64M | SEC |
| 4 | Sep 16, 2024 | Bml Investment Partners, L.P. | 13G | 5.0% | 2.05M | SEC |
| 5 | Mar 22, 2024 | Kidron Nadav | 13D | 5.7% | 2.34M | SEC |
| 6 | Sep 2, 2021 | Kidron Nadav | 13D/A | 4.1% | 1.34M | SEC |
| 7 | Feb 9, 2021 | Slager David Mark | 13G/A | 5.0% | 1.34M | SEC |
| 8 | Feb 14, 2020 | Altium Capital Management LP | 13G/A | 5.0% | 972.0K | SEC |
| 9 | Feb 11, 2020 | Slager David Mark | 13G | 7.4% | 1.32M | SEC |
| 10 | Jan 21, 2020 | Sabby Management, LLC | 13G/A | 5.0% | 885.0K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bml Capital Management, LLC | 3.17M | $10.77M |
| 2 | Aquamarine Financial (Cayman) Ltd | 2.11M | $7.18M |
| 3 | Mercer Global Advisors Inc /Adv | 1.91M | $6.50M |
| 4 | Gem Investment Advisors, LLC | 1.64M | $5.58M |
| 5 | Murchinson Ltd. | 1.32M | $4.47M |
| 6 | Boothbay Fund Management, LLC | 600.7K | $2.04M |
| 7 | Marshall Wace, LLP | 259.6K | $882.7K |
| 8 | Rathbones Group PLC | 233.0K | $792.3K |
| 9 | Dimensional Fund Advisors LP | 158.2K | $537.7K |
| 10 | Wells Fargo & Company/Mn | 157.6K | $535.8K |